how was semaglutide discovered Reflections on the discovery GLP-1 as a satiety hormone: Implications for obesity therapy and future directions Semaglutide protects heart beyond weight

GLP-1 supply issues predicted to carry on As GLP-1 supply issues wage on, European regulators have flagged this situation as a serious public health concern, warning that the shortage is unlikely to resolve within the year

Psychiatry 72 (5), 354360

Subject to the satisfactory completion of these testing milestones, the Company intends to progress the product closer to commercial release as part of The Precision Peptide Company's product portfolio

Effects of recombinant human growth hormone (GH) on bone and intermediary metabolism in patients receiving chronic glucocorticoid treatment with suppressed endogenous GH response to GH-releasing hormone

Mild discomfort at the donor site controlled with paracetamol or mild painkillers

Loss of GPX4 protein expression in NRF1-deficient cells sensitized cells to ferroptosis, whereas in cells lacking GPX4, overexpression of NRF1 failed to inhibit ferroptosis